Bollu et al (2015) reported findings similar to ours that FASN‐dependent palmitoylation positively regulates EGFR and supports cancer cell growth whereas Runkle et al (2016) showed that palmitoylation suppresses EGFR signaling by “pinning” the C‐terminal tail of the receptor to the plasma membrane. This evidence concerns the gene FASN and cancer.